South Korea Asserting Its Contribution in the Asia Pacific Biotech Market
The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research offering.
View full press release